TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy

Title
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 276, Issue 1, Pages 112-120
Publisher
Wiley
Online
2017-03-04
DOI
10.1111/imr.12518

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now